Почетна › Мажорна депресивна поремећеност › Džordžija
Kliničke studije za Мажорна депресивна поремећеност u državi Džordžija
31 studija za Мажорна депресивна поремећеност traži učesnike na lokacijama u državi Džordžija.
Gradovi u državi Džordžija
Zvanični tekst studije (na engleskom)
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Psych Atlanta, Marietta
Тражи се учесникФаза 3
Узраст од 18 до 85 · Оба пола · Ажурирано 13. 11. 2026. · NCT06793397A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Atlanta
- Seaport Investigator Site, Decatur
Тражи се учесникФаза 2
Узраст од 18 до 65 · Оба пола · Ажурирано 10. 11. 2026. · NCT07065240Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium
- Emory Healthcare, Atlanta
Тражи се учесник
Узраст од 22 до 85 · Оба пола · Ажурирано 9. 11. 2026. · NCT07594483A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- CenExel - Atlanta Center for Medical Research, Atlanta
- CenExel - iResearch Atlanta, Decatur
- CenExel - iResearch Savannah, Savannah
Тражи се учесникФаза 3
Узраст од 18 до 74 · Оба пола · Ажурирано 9. 11. 2026. · NCT07592689A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- CenExel iResearch, LLC, Decatur
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT07412756Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- Agile Clinical Research Trials, LLC, Atlanta
Тражи се учесникФаза 3
Узраст од 18 до 74 · Оба пола · Ажурирано 3. 11. 2026. · NCT06559306A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
- Peachford Hospital-Atlanta Behavioral Research, Atlanta
Тражи се учесникФаза 3
Узраст од 12 до 17 · Оба пола · Ажурирано 3. 11. 2026. · NCT07227454A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- CenExel iResearch, LLC, Decatur
- AGILE Clinical Research Trials, LLC, Sandy Springs
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 3. 11. 2026. · NCT07775300Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- The Emory Clinic, Atlanta
- CenExeli Research LLC, Decatur
Тражи се учесникФаза 3
Узраст од 18 до 65 · Оба пола · Ажурирано 3. 11. 2026. · NCT05850689A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Agile Clinical Research Trials, LLC, Atlanta
- Accelerated Clinical Research Group LLC, Snellville
Тражи се учесникФаза 3
Узраст од 18 до 74 · Оба пола · Ажурирано 3. 11. 2026. · NCT07573176Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Atlanta
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT06966401A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- Clinical Research Site, Norcross
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT07621237Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder
- Cenexel Atlanta (ACMR), Atlanta
- Cenexel iResearch Atlanta, Decatur
Тражи се учесникФаза 2
Узраст од 18 до 70 · Оба пола · Ажурирано 28. 10. 2026. · NCT07226661Study of ALTO-300 in MDD
- Site 238, Fayetteville
- Site 293, Stone Mountain
Тражи се учесникФаза 2
Узраст од 18 до 70 · Оба пола · Ажурирано 26. 10. 2026. · NCT05922878Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- Emory University Hospital, Atlanta
Тражи се учесник
Узраст од 22 до 70 · Оба пола · Ажурирано 16. 10. 2026. · NCT06423430A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Decatur
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 14. 10. 2026. · NCT07610473Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Clinical Research Site, Atlanta
- Clinical Research Site, Norcross
- Clinical Research Site, Snellville
Тражи се учесникФаза 3
Узраст од 18 до 65 · Оба пола · Ажурирано 13. 10. 2026. · NCT07484217A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Atlanta
- Draig Clinical Site, Decatur
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 8. 10. 2026. · NCT07300969JAK Signaling in Depression
- Emory University, Atlanta
Тражи се учесникФаза 2
Узраст од 25 до 55 · Оба пола · Ажурирано 28. 9. 2026. · NCT07003997Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, Snellville
Тражи се учесникФаза 3
Узраст од 18 до 65 · Оба пола · Ажурирано 24. 9. 2026. · NCT06830044A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Augusta
Тражи се учесникФаза 4
Узраст 18 и старији · Оба пола · Ажурирано 18. 9. 2026. · NCT07105111Leucine in Midlife Depression
- Emory University Hospital, Atlanta
Тражи се учесникФаза 2
Узраст од 35 до 65 · Оба пола · Ажурирано 11. 9. 2026. · NCT06580145NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Atlanta
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 11. 8. 2026. · NCT06911112Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- CenExel iRS (iResearch Savannah), Savannah
Тражи се учесникФаза 2
Узраст од 18 до 64 · Оба пола · Ажурирано 3. 8. 2026. · NCT06547489A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Denali Health Atlanta, LLC, Stone Mountain
Тражи се учесникФаза 2
Узраст од 18 до 64 · Оба пола · Ажурирано 27. 7. 2026. · NCT07115329A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Trialmed /ID# 277601, Atlanta
- Evergreen Clinical Trials - Norcross /ID# 279421, Norcross
Тражи се учесникФаза 2
Узраст од 18 до 65 · Оба пола · Ажурирано 15. 6. 2026. · NCT07276997Glutamatergic Adaptation to Stress as a Mechanism for Anhedonia and Treatment Response With Ketamine
- Emory University, Atlanta
Тражи се учесникРана фаза 1Здраве особе су добродошле
Узраст од 18 до 65 · Оба пола · Ажурирано 26. 5. 2026. · NCT05327699REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool
- Savannah VA Clinic, Savannah
Тражи се учесникФаза 3Здраве особе су добродошле
Узраст 18 и старији · Оба пола · Ажурирано 29. 4. 2026. · NCT07280065Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- University of Georgia, Athens
Тражи се учесникОпсервациона студија
Узраст од 18 до 40 · Оба пола · Ажурирано 10. 3. 2026. · NCT06740383Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #112, Decatur
- Autobahn Site #142, Peachtree Corners
Тражи се учесникФаза 2
Узраст од 18 до 65 · Оба пола · Ажурирано 20. 1. 2026. · NCT06633016A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Clinical Research Site, Atlanta
Тражи се учесникФаза 4
Узраст од 18 до 65 · Оба пола · Ажурирано 23. 1. 2025. · NCT06223880Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.